Amid its plummeting stock value, layoffs and cuts to its drug R&D program, the battered company is carrying on.
23andMe CEO Anne Wojcicki knows the genetic-testing and ancestry-tracing company has been in "the eye of the storm" recently, but she said she's confident that the company is still viable and ...
It was a simple process. You’d collect a saliva sample, ship it off, and within six weeks, you’d receive a complete ancestral ...
In an exclusive interview with "CBS Mornings" co-host Gayle King, 23andMe CEO Anne Wojcicki discusses the challenges of ...
Hosted on MSN14d
Inside 23andMe CEO Anne Wojcicki's vision for the company: It "will transform health care"In an exclusive interview with "CBS Mornings" co-host Gayle King, 23andMe CEO Anne Wojcicki discusses the challenges of losing family, recent company changes, and her vision for the company's future.
Me was once the darling of DNA testing, but now the ‘spit parties’ are over. After a colossal data breach, its board walked ...
DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief Executive Anne Wojcicki seeks to stabilize her money-losing business. As part ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback